Thierry Poynard

60.6k total citations · 19 hit papers
427 papers, 43.7k citations indexed

About

Thierry Poynard is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Thierry Poynard has authored 427 papers receiving a total of 43.7k indexed citations (citations by other indexed papers that have themselves been cited), including 316 papers in Epidemiology, 289 papers in Hepatology and 45 papers in Surgery. Recurrent topics in Thierry Poynard's work include Liver Disease Diagnosis and Treatment (272 papers), Hepatitis C virus research (218 papers) and Hepatitis B Virus Studies (135 papers). Thierry Poynard is often cited by papers focused on Liver Disease Diagnosis and Treatment (272 papers), Hepatitis C virus research (218 papers) and Hepatitis B Virus Studies (135 papers). Thierry Poynard collaborates with scholars based in France, United States and Germany. Thierry Poynard's co-authors include Pierre Bédossa, Vlad Ratziu, P Opolon, Frédéric Charlotte, Yves Benhamou, John G. McHutchison, Janice K. Albrecht, Ching‐Lung Lai, Françoise Imbert‐Bismut and Man‐Fung Yuen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Thierry Poynard

426 papers receiving 42.2k citations

Hit Papers

An Algorithm for the Grading of Activity in Chronic Hepat... 1996 2026 2006 2016 1996 1997 1998 2005 2003 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Algorithm for the Grading of Activity in Chronic Hepatitis C
    1996 3.3k citations Pierre Bédossa, Thierry Poynard Hepatology profile →
  2. Natural history of liver fibrosis progression in patients with chronic hepatitis C
    1997 2.4k citations Thierry Poynard, Pierre Bédossa et al. profile →
  3. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    1998 1.9k citations Thierry Poynard, Stefan Zeuzem et al. profile →
  4. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
    2005 1.6k citations Vlad Ratziu, Frédéric Charlotte et al. Gastroenterology profile →
  5. Viral hepatitis B
    2003 1.4k citations Ching‐Lung Lai, Vlad Ratziu et al. profile →
  6. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
    2001 1.1k citations Françoise Imbert‐Bismut, Vlad Ratziu et al. profile →
  7. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
    1999 985 citations Yves Benhamou, Vincent Di Martino et al. Hepatology profile →
  8. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    2002 849 citations Thierry Poynard et al. Gastroenterology profile →
  9. Liver fibrosis in overweight patients
    2000 786 citations Vlad Ratziu, Frédéric Charlotte et al. Gastroenterology profile →
  10. Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
    2002 775 citations Thierry Poynard et al. Gastroenterology profile →
  11. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
    2009 673 citations Thierry Poynard et al. Gastroenterology profile →
  12. Viral hepatitis C
    2003 664 citations Thierry Poynard, Ching‐Lung Lai et al. profile →
  13. Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
    1996 573 citations Thierry Poynard, Philippe Mathurin et al. Hepatology profile →
  14. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
    2001 548 citations Thierry Poynard, Vlad Ratziu et al. Journal of Hepatology profile →
  15. Liver Fibrosis in Viral Hepatitis: Noninvasive Assessment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography
    2009 532 citations Mireen Friedrich‐Rust, Eva Herrmann et al. profile →
  16. Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients With Gastrointestinal Bleeding: A Meta–Analysis
    1999 520 citations Brigitte Bernard, P Opolon et al. Hepatology profile →
  17. Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
    2008 503 citations Vlad Ratziu, Frédéric Charlotte et al. Gastroenterology profile →
  18. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
    2013 380 citations Frédéric Charlotte, Pierre Bédossa et al. Journal of Hepatology profile →
  19. Chronic hepatitis C virus (HCV) disease burden and cost in the United States
    2012 372 citations Thierry Poynard et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Poynard France 93 36.1k 33.9k 4.3k 3.3k 3.1k 427 43.7k
Zachary Goodman United States 88 33.3k 0.9× 31.0k 0.9× 4.5k 1.0× 2.9k 0.9× 1.9k 0.6× 299 42.1k
Jay H. Hoofnagle United States 109 30.6k 0.8× 30.1k 0.9× 4.2k 1.0× 2.7k 0.8× 1.5k 0.5× 393 43.8k
Mitchell L. Shiffman United States 75 27.7k 0.8× 27.9k 0.8× 3.1k 0.7× 2.4k 0.7× 1.2k 0.4× 275 34.4k
Adrian M. Di Bisceglie United States 89 24.4k 0.7× 24.7k 0.7× 2.5k 0.6× 1.6k 0.5× 1.5k 0.5× 385 34.5k
Antonio Craxı̀ Italy 73 20.5k 0.6× 20.4k 0.6× 2.5k 0.6× 1.8k 0.5× 1.7k 0.6× 519 27.1k
Stefan Zeuzem Germany 101 32.8k 0.9× 34.2k 1.0× 4.1k 0.9× 1.5k 0.5× 2.0k 0.6× 1.0k 47.0k
Anna S. Lok United States 105 40.9k 1.1× 39.5k 1.2× 3.9k 0.9× 1.1k 0.3× 1.3k 0.4× 557 48.3k
Norah A. Terrault United States 82 21.2k 0.6× 19.7k 0.6× 3.9k 0.9× 2.1k 0.6× 2.0k 0.6× 457 26.8k
K. Rajender Reddy United States 88 24.9k 0.7× 28.3k 0.8× 5.3k 1.2× 610 0.2× 1.2k 0.4× 586 37.2k
Vincent Wai‐Sun Wong Hong Kong 104 33.2k 0.9× 20.9k 0.6× 7.8k 1.8× 8.6k 2.6× 3.6k 1.2× 635 44.7k

Countries citing papers authored by Thierry Poynard

Since Specialization
Citations

This map shows the geographic impact of Thierry Poynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Poynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Poynard more than expected).

Fields of papers citing papers by Thierry Poynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Poynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Poynard. The network helps show where Thierry Poynard may publish in the future.

Co-authorship network of co-authors of Thierry Poynard

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Poynard. A scholar is included among the top collaborators of Thierry Poynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Poynard. Thierry Poynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermehren, Johannes, Amina Carlebach, Thomas A. Lutz, et al.. (2012). Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers. BMC Gastroenterology. 12(1). 27–27. 19 indexed citations
2.
Poynard, Thierry, M. Munteanu, Olivier Deckmyn, et al.. (2011). Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age. BMC Gastroenterology. 11(1). 39–39. 52 indexed citations
3.
Poynard, Thierry, Yen Ngo, Françoise Imbert‐Bismut, et al.. (2008). Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroentérologie Clinique et Biologique. 32(6). 8–21. 34 indexed citations
4.
Rosenthal‐Allieri, Maria Alessandra, Albert Tran, Philippe Halfon, et al.. (2007). Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique. 31(10). 815–821. 4 indexed citations
5.
Munteanu, M., Pierre Bédossa, Delphine Dargère, et al.. (2007). Diagnostic value of serum protein profiling by SELDI‐TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 26(6). 847–858. 33 indexed citations
6.
Poynard, Thierry, Philippe Halfon, Laurent Castéra, et al.. (2007). Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Alimentary Pharmacology & Therapeutics. 25(6). 733–739. 81 indexed citations
7.
Lai, Ching‐Lung, Myron J. Tong, Florence Wong, et al.. (2005). Phase Iib Extended-Treatment Trial of Telbivudine (LdT) Vs Lamivudine Vs Combination Treatment in Hepatitis B Patients: Two-Year Results. Gastroenterology. 12 indexed citations
8.
Lai, Ching‐Lung, Nancy Leung, Eng Kiong Teo, et al.. (2005). A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B. Gastroenterology. 129(2). 528–536. 304 indexed citations
9.
Soriano, Vincent, Mark Sulkowski, Colm Bergin, et al.. (2002). Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel. AIDS. 16(6). 813–828. 344 indexed citations
10.
Myers, Robert P., Corinne Regimbeau, J. Moussalli, et al.. (2002). Quelles sont les indications du traitement dans l'hépatite C aiguë ?. Gastroentérologie Clinique et Biologique. 21. 188–193. 2 indexed citations
11.
Lazar, Vladimir, Pierre Validire, Sophie Richon, et al.. (2002). Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. British Journal of Cancer. 86(8). 1283–1289. 21 indexed citations
12.
Poynard, Thierry, Sylvie Naveau, Michel Doffoël, et al.. (1999). Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Journal of Hepatology. 30(6). 1130–1137. 80 indexed citations
13.
Deuffic‐Burban, Sylvie, Laurent Buffat, Thierry Poynard, & Alain‐Jacques Valleron. (1999). Modeling the Hepatitis C Virus Epidemic in France. Hepatology. 29(5). 1596–1601. 164 indexed citations
14.
Sobesky, Rodolphe, Philippe Mathurin, Frédéric Charlotte, et al.. (1999). Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view. Gastroenterology. 116(2). 378–386. 207 indexed citations
15.
Naveau, Sylvie, et al.. (1992). Cirrhosis as an independent risk factor for colonic adenomas.. Gut. 33(4). 535–540. 29 indexed citations
16.
Biour, M, J.–M. Davy, Thierry Poynard, & Vincent Lévy. (1990). [Is fluindione hepatotoxic?].. PubMed. 14(10). 782–782. 4 indexed citations
17.
Chaput, J C, et al.. (1985). Psoriasis, alcohol, and liver disease.. BMJ. 291(6487). 25.1–25. 40 indexed citations
18.
Gin, H., et al.. (1981). Metformin reduces post prandial insulin needs in type 1 diabetics assessment by the artificial pancreas. Diabetologia. 21(3). 329. 7 indexed citations
19.
Beaugrand, Michel, Thierry Poynard, P Callard, et al.. (1981). Recherche d'une infection à cytomégalovirus au cours des colites pseudo-membraneuses. 6 observations.. ˜La œNouvelle presse médicale. 10(15). 2 indexed citations
20.
Poynard, Thierry, et al.. (1977). [Intestinal functional disorders: review of the literature].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(8-9). 681–704. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zachary Goodman Breakdown of academic impact, for papers by Jay H. Hoofnagle Breakdown of academic impact, for papers by Mitchell L. Shiffman Breakdown of academic impact, for papers by Adrian M. Di Bisceglie Breakdown of academic impact, for papers by Antonio Craxı̀ Breakdown of academic impact, for papers by Stefan Zeuzem Breakdown of academic impact, for papers by Anna S. Lok Breakdown of academic impact, for papers by Norah A. Terrault Breakdown of academic impact, for papers by K. Rajender Reddy Breakdown of academic impact, for papers by Vincent Wai‐Sun Wong
Rankless by CCL
2026